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Weight of Dialysis Patients in Pakistan
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Departments of 1Medicine, 2Community Health Sciences, 3Medical College, Aga Khan University
Hospital, Karachi, Pakistan
ABSTRACT. Accurate dry weight estimation (DW) to achieve euvolemia is one of the key
objectives of hemodialysis (HD). While conventionally DW is estimated by clinical examination,
bioelectrical impedance analysis (BIA) has been proposed as an objective method to determine
DW and has been tested extensively in the Western population. We aim to validate BIA for
determining DW in a Pakistani population against the conventional clinician’s method. This is a
single-center validation study conducted at two outpatient HD units of Aga Khan Hospital,
Karachi. One hundred and forty-eight DW readings of patients who were on maintenance HD
were taken both by BIA technology and by clinical assessment. The clinician was blinded to
readings obtained by BIA. Data analysis was carried out using the Statistical Package for Social
Sciences (SPSS) version 19. Median age of patients was 63 years (range 12–89). Nearly 54.1% of
the samples were female (n = 80). Spearman’s correlation between the clinician’s estimate and
BIA-derived DW showed a correlation coefficient of 0.982, which was statistically significant (P
<0.001). This association remained significant when stratified analysis was carried out by
dividing the sample into subgroups according to age, gender, body mass index, and total body
water content. Inter-rater reliability analysis using the kappa statistics showed almost perfect
agreement between the two methods, κ = 0.929 (95% confidence interval, 0.878–0.980, P
<0.001). BIA has been validated as a tool for DW assessment of HD patients in Pakistan in com-
parison to clinical method.
Introduction
  Ultrafiltration to achieve preset dry weight
(DW) is one of the prime aspects of hemodia-
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lysis (HD) prescription.1,2 Defined as the lo-
west weight that a patient can tolerate without
developing symptoms of fluid imbalance; DW
is the target weight that a patient should reach
at the end of each dialysis session.3
  Establishment of accurate DW is pivotal in
maintaining quality of life of patients receiving
HD treatment.4 Achieving “normohydration”
or appropriate DW is associated with longer
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over-hydration have deleterious consequences.
Chronic volume overload is directly associated
with hypertension, increased arterial stiffness,
left ventricular hypertrophy, heart failure, and
subsequently higher mortality.2 Almost 80% of
all hypertension in dialysis patients are related
to chronic hypervolemia.2 Dehydration, on the
other hand, results in hypotension, tinnitus,
dizziness, and cramps and increases the chance
of cardiac or neurological ischemic events, vas-
cular access thrombosis, and dysrhythmias.2,6-8
  Traditional DW estimation is done by clinical
examination, especially blood pressure moni-
toring and is based on a trial and error method
until euvolemia is achieved.9 Clinical assess-
ment is a feasible method for determining and
achieving DW.9 However, this requires exper-
tise of a skilled onsite nephrologist. Moreover,
clinical decision-making is complicated by
factors such as heart failure, third-spaced fluid,
and presence of renin-mediated blood pressure
surges which are common in dialysis popu-
lation. The conventional method of DW
assessment may also fall short to account for
ongoing changes in nutritional status effecting
lean body mass.1,10
As there is a significant relationship between
the correct estimation of DW and outcomes
and clinical difficulty in fluid management of
dialysis patients, the natural inclination is to
turn to technology.11 Therefore, various objec-
tive methods have been proposed, including
biochemical indicators, bioelectrical impe-
dance technique, and online real-time blood
volume monitoring.12
  The basic principles of bioelectrical impe-
dance were initially described by Thomassett
in 1963.13 These measurements are based on
the basic principle that the electrical impe-
dance of a cylinder is directly proportional to
its length and inversely proportional to its
cross-sectional area multiplied by its specific
resistivity. Assuming that the human body is a
sum of homogeneous cylinders and that cur-
rent would pass only through ion- and water-
containing media; in 1969, Hoffer was the first
to attempt to measure total body water by this
method.14
Bioelectrical impedance analysis (BIA) is a
noninvasive method to determine body com-
position and DW in HD patients with inter-
observer and intraobserver error of <2%,
making it a reliable tool for fluid management
in HD patients.1 In recent years, BIA devices
have been extensively tested in the Western
population to aid clinical decision-making of
DW estimation in HD patients. There is emer-
ging evidence of its usefulness in tailoring the
dialysis prescription based on individual
patient needs.1,15 The reproducibility of this
method permits a long-term follow-up of
changes in the hydration status of dialysis
patients which is particularly useful in case of
occurrence of acute or chronic comorbid
conditions.16
  Furthermore, while BIA has been validated in
Caucasian adults, it is not known whether the
prediction equations on which it functions are
applicable to all HD patients worldwide.17 The
body composition of Asians is quite different
from that of Caucasians in terms of fat content
and lean mass.18,19 Previously, BIA data on
end-stage renal disease (ESRD) patients avai-
lable from South Asia has been provided by
one study conducted in India; however, a large
proportion of that population is vegetarian,
which makes their body composition different
and limits the applicability of previous studies
on Pakistani population.20 Body composition
affects the electrical impedance and therefore
the BIA derived DW of the patient, necessi-
tating the validation of BIA in Pakistan. In
addition, previous studies have identified a
discrepancy between BIA and clinically de-
rived DW at extremes of body mass index
(BMI) and recommend the validation of BIA
in such scenarios.21 Our objective in this study
was to validate DW estimation by BIA in
patients with ESRD undergoing HD against
DW estimation by conventional (clinical)
method, which is considered the gold standard.
Subjects and Methods
  This is a single-center validation study in
which we validated the use of BIA for DW
determination in comparison to the gold stan-
dard - clinician’s method (CM).
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  This study was conducted in two outpatient
HD units of Aga Khan University Hospital
(AKUH), Karachi, Pakistan, from November
2014 to February 2015. Data collection was
commenced after receiving approval from the
Ethical Review Committee of AKUH.
Informed consent was taken from each
participating individual in line with the ethical
norms. The purpose and procedure of the
study was explained to the participants, and
consent forms were made available to them in
English as well as in local language “Urdu.”
  One hundred and forty-eight DW readings of
patients who were on maintenance HD were
taken both by the BIA technology using
Maltron BioScan 915, 916 S and by simul-
taneous clinical assessment by trained/trainee
nephrologists. Each patient was included to the
maximum of 3 times in the study. For those
patients who were included more than once in
the study, the readings were taken at least one
month apart. Those patients who developed
intradialytic hypotension during their dialysis
session were excluded from the study.
  The inclusion criteria were patients with
ESRD who were on maintenance HD for more
than three months and were stable, with no
hospitalization history during the last one
month. Participants were excluded if they were
pregnant, had a pacemaker, had ascites, or
were known cases of nephrotic syndrome.
  DW of each patient was assessed first by the
clinician and then by BIA before the start of
each HD session. Thus, the nephrologist was
blinded to the DW reading obtained by BIA.
  Before the dialysis session, patients were cli-
nically assessed by the nephrologist for edema
and effusion (crackles on chest examination,
ankle edema, ascites, jugular venous pressure,
and blood pressure were checked). The weight
at which patient had no abnormal findings
suggestive of volume overload and further
dialysis may lead to hemodynamic disturbance
was considered as clinical DW (CDW). DW in
all patients was also measured by a single-
frequency bioelectric impedance analyses de-
vice (BioScan 915, 916 S). The device has
four electrodes. Two electrodes are attached to
the upper extremity which do not have arterio-
venous fistula (wrist and dorsum of 3rd meta-
carpi), and two electrodes are attached to the
ankle and dorsum of the third metatarsal.
Basic information including height, weight,
age, and sex was recorded, and then, the
BioScan calculates the DW along with other
body composition parameters. DW measure-
ment was performed before beginning the dia-
lysis session. To standardize the procedure,
BIA measurements were taken with the pa-
tients in fasting condition, supine position with
the limbs spread apart, and after voiding urine.
Room temperature was maintained in the
dialysis units where these readings were taken.
  In addition, blood pressure readings were
checked before the start, during, and after the
completion of HD along with the heart rate
and oxygen saturation. Patients were assessed
by the nephrologist before, during the session,
and at the end of HD for signs and symptoms
of over- and under-hydration.
  Data analysis was carried out using the
Statistical Package for Social Sciences (SPSS)
version 19.0, IBM Corp., Armonk, NY, USA.
Median and interquartile ranges were reported
for continuous variables. Continuous variables
were also divided on the basis of gender and
then their median and interquartile ranges were
generated and compared using Mann–Whitney
U-test. Percentages were obtained for cate-
gorical variables.
  Kolmogorov–Smirnov test showed that the
values of DW by both methods were not
normally distributed; hence, Spearman’s corre-
lation was applied to find the strength of
association between the two methods of DW
determination.
  Bland–Altman analysis was used to assess
agreement and bias. Inter-rater reliability
analysis was performed to determine agree-
ment between values of DW determined by
BIA and CM. This was done by computing
intraclass correlation coefficient (ICC) and
kappa statistics. For kappa statistic, the values
of DW were ranked in ascending order and
divided into tertiles. The observed level of
agreement was determined by cross-tabulating
the values of DW by both methods, and
expected level of agreement was determined by
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marginal frequencies. 95% confidence interval
(CI) was used for both measures.
Results
  In this study, 148 readings were taken to
assess the DW of HD patients in AKUH using
bioimpedance analysis and compared it to the
CDW. Among 148 readings, 80 readings of
DW were of female dialysis patients and 68
were of males. A total of 82 (55.4%) out of
148 readings were of patients with diabetes
mellitus while 99 (66.8%) had a history of
hypertension. Figure 1 shows the distribution
of comorbidities in our study population.
  Median age of patients was 63 years (range
12–89 years), with median age of male pa-
tients being 62 years and of females being 64
years. Median BMI was 24.20 (range 12.20–
47.20) for the combined sample population.
Thirteen (8.7%) of these patients were under-
weight (BMI <18.5) while 71 (47.9%) were of
normal weight (BMI 18.5–24.99), 46 (31%)
were overweight (BMI 25–29.9), and 18
(12.1%) were obese (BMI ≥30).
Paired sample t-test showed a significant
reduction in blood pressure was achieved at
the end of HF. Cardiovascular parameters of
the study population have been summarized in
Table 1.
  Spearman’s correlation showed that there
was a significant association between values
of DW obtained by BIA and clinical method
(P <0.001). In addition, stratified analysis done
by dividing the sample into subgroups accor-
ding to age, gender, BMI, total body water
content, and presence or absence of diabetes as
comorbidity showed that the association
remained a significant regardless of these
factors. Figure 2 shows the graphical represen-
tation of DW measured by both methods.
  An inter-rater reliability analysis using the
kappa statistic was performed to determine
consistency between DW determined by BIA
Figure 1. Distribution of comorbid conditions among the study population.
DM: Diabetes mellitus, HTN: Hypertension, HD: Ischemic heart disease, CVA: Cerebrovascular
accident, AHUS: Atypical hemolytic uremic syndrome, SLE: Systemic lupus erythematosus, CLD:
Chronic liver disease, Hep C: Hepatitis C, Bladder CA: Urinary bladder carcinoma.
Table 1. Mean ± standard deviation of hemodynamic parameters of study population.
Hemodynamic parameters Predialysis Postdialysis P
Heart rate (bpm) 80±13 81±16 0.398
Systolic blood pressure (mm Hg) 154±21 144±21 0.006
Diastolic blood pressure (mm Hg) 77±16 74±15 <0.001
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and CM. There was almost perfect agreement
between the two methods, κ = 0.929 (95% CI,
0.878–0.980), P <0.001. These results were
corroborated by computing the ICC, a second
measure of reliability. The value of ICC was
0.996 (95% CI, 0.995–0.997), P <0.001, again
indicating almost perfect agreement between
the two methods.
Discussion
  This study demonstrates the utility of BIA in
the determination of DW in a South Asian
population. DW measured by BIA was com-
pared with the conventional method of estima-
tion by clinical judgment and symptomato-
logy. Clinical assessment remains the foun-
dation for DW determination with several
methods currently being investigated to aid
this process.16
  We found a significant association between
the values of DW determined by both me-
thods. These results are corroborated by
similar studies done in Western populations.17
BIA appears to have significant potential in
the assessment of hydration status and
measurement of DW.11 A study done in 2000
by Cooper et al concluded that the values of
total body water varied significantly depending
on the method of calculation and that BIA was
the most accurate method of determining
patients’ body composition.22 Another study
done in Iran concluded that an accurate esti-
mate of the DW can be made by combining
the conventional method of measurement and
BIA and determining the correlation between
values from the two methods even though the
conventional method is time consuming and
dependent on the attributes of the professional
performing the measurements.10
  Body composition, fat/mineral content, and
volume distribution are significantly different
in South Asian/Asian Indian populations com-
pared to Caucasians. These differences can
potentially effect DW assessment by devices
that were initially tested in Caucasian popu-
lation and not validated in the South Asian/
Indian population.18,19 Therefore, we compared
the DW assessed by clinical method with the
DW assessment by BIA technique in a South
Asian population. Our study showed a signi-
ficant association as depicted by the linear
scattered graph for overall population. This
association held true in all subgroup analyses
according to age, gender, BMI, and total body
water and in the diabetic and nondiabetic
population. This was an important finding in
our study as previous studies have recommen-
ded the validation of BIA in patients at extremes
of BMI ranges.21 BMI of the participants in the
Figure 2. Scattered graph: Association of dry weight measured by BIA versus clinical method.
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present study ranged from 12.20–47.20, provi-
ding a fairly representative sample.
  We used a single-frequency BIA device in
this study. The use of multiple frequencies,
usually termed as bioimpedance spectroscopy,
enables calculation of theoretical resistance
values at zero and infinite frequencies by
fitting a polynomial curve termed as Cole-
Cole plot and thus improving the accuracy of
equations that are used to determine intra-
cellular and extracellular fluid compartments.23
Some studies show that single-frequency bio-
impedance and multiple-frequency spectros-
copy are both equally accurate in measuring
total body water and intracellular fluid.24,25
  This study was the first of its kind in
Pakistan. DW estimation using BIA is a
relatively uninvestigated entity in our part of
the world, specifically in South Asia. Further-
more, several possible sources of bias have
been identified in the literature when using
BIA which include body position, food intake,
environmental conditions, temperature of the
skin, and bladder content.21 These were elimi-
nated in our study by following standardized
conditions.
  Limitations of the current study were that it
was a single-center study with a small patient
population. In addition, we used a single-
frequency BIA device which is simpler and
easier to use than multifrequency BIA;
however, while certain studies claim that both
types of devices are equally accurate, other
studies report that the inability to make an
accurate distinction between extracellular and
intracellular volume with a single-frequency
device is a possible limitation.2
  Each individual technique of DW estimation
has its limitations. According to Purcell et al,
DW cannot be determined in any patient by a
single parameter.26 Whatever new technologies
we apply, attention to careful clinical exami-
nation and history would continue to play an
important role in optimizing fluid manage-
ment. Therefore, combination of BIA tech-
nique with the clinical method for the correct
DW estimation should be used and tested.
  It is obvious that our study is only an initial
step toward the process of accurate estimation
of DW, and hopefully, it will result in further
investigation in this field in our population.
We feel that BIA has been validated as a tool
for DW assessment of HD patients in Pakistan
in comparison to clinical method.
Conflict of interest:  None declared.
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